FORT LAUDERDALE & MIRAMAR, Fla.--(BUSINESS WIRE)--Home Diagnostics, Inc. and Nipro Diabetes Systems, Inc. today announced that the two companies will merge to become Nipro Diagnostics, Inc. Both companies are wholly-owned by Nipro Corporation, a multi-billion dollar company headquartered in Osaka, Japan and a world leader in providing medical products to the healthcare community.
Home Diagnostics, Inc., based in Fort Lauderdale, Florida, manufactures and markets the TRUE brand of quality, high-performance blood glucose monitoring systems. Home Diagnostics is the co-brand supplier of blood glucose monitoring systems for leading national retail pharmacies, pharmacy wholesalers, medical products distributors and mail-order suppliers. Nipro Diabetes Systems, located in Miramar, Florida, is the manufacturer and marketer of the Amigo® Insulin Pump.
The merger of the two companies results in a comprehensive diabetes monitoring and insulin management product portfolio, which few companies offer. This portfolio will help to ensure that patients and their healthcare professionals have easy access to the high-quality diabetes monitoring and management tools they need to improve quality of life.
Both companies share a vision of making diabetes monitoring and management more affordable and are already well-positioned in the quality-value segment of their respective categories.
“Our mission at Home Diagnostics has always been to make high-performance blood glucose monitoring technology more affordable to people with diabetes,” said Joseph Capper, president of Home Diagnostics, Inc. “Merging with Nipro Diabetes Systems helps us extend this mission to the insulin pump category.”
The name change to Nipro Diagnostics, Inc. is effective immediately for Home Diagnostics. The merger of the two companies is expected to be completed by the end of the year.